Extracellular Vesicles as Potential Biomarkers for Early Detection and Diagnosis of Pancreatic Cancer
Open Access
- 7 December 2020
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 8 (12) , 581
Abstract
Pancreatic carcinoma (PC) is highly metastatic, and it tends to be detected at advanced stages. Identifying and developing biomarkers for early detection of PC is crucial for a potentially curative treatment. Extracellular vesicles (EVs) are bilayer lipid membrane-structured nanovesicles found in various human bodily fluids, and they play important roles in tumor biogenesis and metastasis. Cancer-derived EVs are enriched with DNA, RNA, protein, and lipid, and they have emerged as attractive diagnostic biomarkers for early detection of PC. In this article, we provided an overview of the cell biology of EVs and their isolation and analysis, and their roles in cancer pathogenesis and progression. Multiplatform analyses of plasma-based exosomes for genomic DNA, micro RNA, mRNA, circular RNA, and protein for diagnosis of PC were critically reviewed. Numerous lines of evidence demonstrate that liquid biopsy with analysis of EV-based biomarkers has variable performance for diagnosis of PC. Future investigation is indicated to optimize the methodology for isolating and analyzing EVs and to identify the combination of EV-based biomarkers and other clinical datasets, with the goal of improving the predictive value, sensitivity, and specificity of screening tests for early detection and diagnosis of PC.Keywords
This publication has 114 references indexed in Scilit:
- Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinomaWorld Journal of Surgical Oncology, 2013
- Role of Pancreatic Cancer-derived Exosomes in Salivary Biomarker DevelopmentJournal of Biological Chemistry, 2013
- Alkaline Phosphatase ALPPL-2 Is a Novel Pancreatic Carcinoma-Associated ProteinCancer Research, 2013
- Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line TherapyFrontiers in Oncology, 2013
- Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapyNature Medicine, 2012
- The prognostic and predictive value of serum CA19.9 in pancreatic cancerAnnals of Oncology, 2012
- A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarkerBritish Journal of Cancer, 2011
- Tumour microvesicles contain retrotransposon elements and amplified oncogene sequencesNature Communications, 2011
- Glypican-1 Is Frequently Overexpressed in Human Gliomas and Enhances FGF-2 Signaling in Glioma CellsThe American Journal of Pathology, 2006
- CA19-9 as a Screening and Diagnostic Tool in Symptomatic PatientsPancreas, 1994